---
title: "Repatha (evolocumab), all indications: Storage and supply questions"
description: "Storage and supply questions on Repatha (evolocumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: How supplied and Storage. Questions: What forms does Repatha come in? Is the Repatha prefilled syringe being discontinued? How should Repatha be stored? How long can Repatha be kept at room temperature? 4 questions quoted from 3 sources."
canonical: "https://www.evicenter.com/medical-information/repatha/storage-and-supply"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Repatha (evolocumab), all indications: Storage and supply questions

Manufacturer: Amgen Inc.  
Prescribing information: [Repatha](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf)  
Indication pages: [Cardiovascular event risk reduction](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction)

## How supplied

<a id="repatha-dosage-forms"></a>

### What forms does Repatha come in?

> “REPATHA injection is a clear to opalescent, colorless to pale yellow solution available as follows: 
>
> • 
> 140 mg/mL solution in a prefilled single-dose pen 
> • 
> 140 mg/mL solution in a prefilled single-dose SureClick<sup>®</sup> autoinjector 
> • 
> 140 mg/mL solution in a prefilled single-dose syringe”

Source: [REPATHA: Prescribing information, page 3, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=3)

Note: The Prescribing Information revised 10/2026 lists the prefilled single-dose syringe; the Repatha HCP site, as captured on November 13, 2026, states that Amgen planned to discontinue it by Q1 2026. The site's discontinuation notice describes two device presentations (the SureClick autoinjector and the prefilled syringe) and does not mention the prefilled single-dose pen.

<a id="repatha-prefilled-syringe-discontinued"></a>

### Is the Repatha prefilled syringe being discontinued?

> “Amgen has made the decision to discontinue the Repatha<sup>®</sup> prefilled syringe.”

Source: [REPATHA: Prefilledsyringeupdate, captured 2026-11-13](https://www.repathahcp.com/prefilledsyringeupdate#:~:text=Amgen%20has%20made%20the%20decision,prefilled%20syringe.)

> “We plan to discontinue the Repatha<sup>®</sup> prefilled syringe by Q1 2026. All patients should transition to the SureClick<sup>®</sup> autoinjector not made with natural rubber latex and require a new prescription.”

Source: [REPATHA: Prefilledsyringeupdate, captured 2026-11-13](https://www.repathahcp.com/prefilledsyringeupdate#:~:text=We%20plan%20to%20discontinue%20the,and%20require%20a%20new%20prescription.)

> “HCP Action Required:
>
> Refrain from prescribing the prefilled syringe for any new Repatha<sup>®</sup> patients.
> Transition all refill patients to the SureClick<sup>®</sup> autoinjector (NDC 72511-393-02).
> Educate transitioning patients that this is a device change only—their medication and dose remain unchanged.”

Source: [REPATHA: Prefilledsyringeupdate, captured 2026-11-13](https://www.repathahcp.com/prefilledsyringeupdate#:~:text=HCP%20Action%20Required%3A,medication%20and%20dose%20remain%20unchanged.)

> “Prefilled single-dose syringe
> Discontinued
>
> The Repatha<sup>®</sup> prefilled single-dose syringe will be discontinued
> effective Q1 2026.
>
> 140 mg/mL prefilled
> single-dose syringe
> (NDC 72511-501-01)”

Source: [REPATHA: Prefilledsyringeupdate, captured 2026-11-13](https://www.repathahcp.com/prefilledsyringeupdate#:~:text=prescription%20to%20transition.-,Prefilled%20single%2Ddose%20syringe,%28NDC%2072511%2D501%2D01%29)

> “Q: Will this action lead to supply shortages? 
> •
> Amgen has sufficient product to supply patients during their transition from the prefilled syringe.”

Source: [REPATHA: Repatha-prefilled-syringe-update-FAQs-for-HCPs, page 1, captured 2026-11-13](https://www.repathahcp.com/~/media/Themes/Amgen/RepathaHcp-com/RepathaHcp-com/Documents/PDFs/Repatha-prefilled-syringe-update-FAQs-for-HCPs#page=1)

Note: The notice and the FAQ (dated 2025) are as captured from the Repatha HCP site on November 13, 2026, after the Q1 2026 date they give. The Prescribing Information revised 10/2026 still lists prefilled single-dose syringes (NDC 72511-501-01 and 72511-750-01); the notice names NDC 72511-501-01.

## Storage

<a id="repatha-storage"></a>

### How should Repatha be stored?

> “Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze. 
> Do not shake.”

Source: [REPATHA: Prescribing information, page 26, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=26)

<a id="repatha-room-temperature"></a>

### How long can Repatha be kept at room temperature?

> “REPATHA prefilled single-dose pen, prefilled single-dose SureClick<sup>®</sup> autoinjector, or prefilled 
> single-dose syringe may also be kept at room temperature at 68°F to 77°F (20°C to 25°C) in the original 
> carton for 30 days. If not used within the 30 days, discard REPATHA.”

Source: [REPATHA: Prescribing information, page 26, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=26)

## Related pages
- [Medical information: Repatha (evolocumab): All indications](https://www.evicenter.com/medical-information/repatha)
- [Indication](https://www.evicenter.com/medical-information/repatha/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/repatha/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/repatha/safety)
- [Specific populations](https://www.evicenter.com/medical-information/repatha/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/repatha/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/repatha/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/repatha/access-and-coverage)
